Rights Offering Final Price Set at 4,860 Won
-
Final issue price set at 4,860 won for 16,830,200 new common shares.
-
The final price is the lower of the 1st issue price (6,260 won) and 2nd issue price (4,860 won).
-
Finalization date: 2026-05-08, disclosure on 2026-05-11.
-
Rights offering followed by public offering for unsubscribed shares; dilution risk for existing shareholders.
KOSDAQ Filing Information
-
Filing: Determination of Final Issuance Price for Rights Offering
-
Company: ImmuneOncia Therapeutics (424870)
-
Submission: ImmuneOncia Therapeutics, Inc.
-
Receipt: 05-08-2026
-
Under KRX KOSDAQ Market Division